E Schulze

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Mutational Spectrum of the Steroid 21-Hydroxylase Gene in Austria: Identification of a Novel Missense Mutation

Sabina Baumgartner‐Parzer, E Schulze, W Waldhäusl et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 70 citations · Full text

Family Members, Unrelated Austrian Patients, Genetics +20

Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid-21-hydroxylase

E Schulze, Gunter Scharer, A. Rogatzki et al. · Endocrine Research · 1995 · 48 citations

Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas

Christiane Maser‐Gluth, Martín Reincke, Bruno Allolio et al. · European Journal of Clinical Investigation · 2000 · 33 citations